← Eichor
Condition: Immune Surveillance Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immune Surveillance

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Rheumatoid Arthritis Remission Screening and Prospective Surveillance
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07571993Transfusion Surveillance in Anaesthesia
Phase N/A · 1 location(s) · Erasme University Hospital · NCT06403163A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Mye
Phase N/A · 5 location(s) · Bristol-Myers Squibb · NCT06698887Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Phase N/A · 1 location(s) · Pfizer · NCT05754710Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees
Phase N/A · 2 location(s) · Jacobs University Bremen gGmbH · NCT06899308Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429Acute Immune Modulation by Probiotic Strain
NA · 1 location(s) · Natural Immune Systems Inc · NCT06754228Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Phase N/A · 1 location(s) · Rodolfo Alejandro · NCT02000687Clinical Trial: Rapid Immune Modulating Effects
NA · 1 location(s) · Natural Immune Systems Inc · NCT07195552Anti-viral Action Against Type 1 Diabetes Autoimmunity
Phase 4 · 9 location(s) · Technical University of Munich · NCT06452654STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06337097A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis
Phase N/A · 1 location(s) · Pfizer · NCT05391061Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT04933552Kesimpta (Ofatumumab) Pregnancy Registry
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT05634967A 24-week rPMS Study in Real-world Setting for Enerzair
Phase N/A · 20 location(s) · Novartis Pharmaceuticals · NCT05274425A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome
Phase N/A · 2 location(s) · Novartis Pharmaceuticals · NCT07598422A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Phase N/A · 18 location(s) · Novartis Pharmaceuticals · NCT05217810Twiist Postmarket Surveillance Study for Type 1 Diabetes
Phase N/A · 1 location(s) · Deka Research and Development · NCT07356089The iLet Experience Study
Phase N/A · 1 location(s) · Beta Bionics, Inc. · NCT06891898A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Phase N/A · 1 location(s) · Takeda · NCT05481437A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
Phase N/A · 3 location(s) · Novartis Pharmaceuticals · NCT07416162Rapid Response of Stem Cells and Immune Cells for Efficacy
NA · 1 location(s) · Natural Immune Systems Inc · NCT07127705A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · 59 location(s) · Eisai Korea Inc. · NCT06246123Clinical Trial on Rapid Immune Modulating Effects
NA · 1 location(s) · Natural Immune Systems Inc · NCT07206407Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cose
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07243782Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Phase N/A · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT01408225General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
Phase N/A · 112 location(s) · Novo Nordisk A/S · NCT06807190Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Phase N/A · 6 location(s) · Kyowa Kirin Co., Ltd. · NCT07132567To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
Phase N/A · 2 location(s) · Desmond Tutu TB Centre · NCT06902194
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.